Adverse Events in Clinical Trials Non Clinical Safety Evaluation and Adverse Events in Phase I Trials Pharmacovigilance Safety Profile for ENTYVIO (vedolizumab) Adverse Events in Clinical Trials Non Clinical Safety Evaluation and Adverse Events in Phase I Trials Pharmacovigilance CJC 1295 and Ipamorelin Dosage Guide: Benefits & Safety Vita Bella Health Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin Adverse Event Reporting in Clinical Trials